<DOC>
	<DOCNO>NCT02885376</DOCNO>
	<brief_summary>The primary objective study determine efficacy Dentoxol® mouthrinse reduce severity oral mucositis secondary radiation therapy head neck cancer .</brief_summary>
	<brief_title>Study Dentoxol® Mouthrinse Oral Mucositis</brief_title>
	<detailed_description />
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>Planned receive radiation therapy cancer oral cavity , oropharynx , nasopharynx , hypopharynx larynx , without concomitant chemotherapy . Planned receive least 5000cGy radiation therapy least 2 12 prespecified area oral cavity Unable give write informed consent Known allergy/intolerance component study rinse placebo Planning use contraindicate medication study period ( pain medication allow ) Age 18 year Pregnant nursing ( If patient woman childbearing potential , pregnancy test must perform within fourteen day enrollment study )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Mucositis</keyword>
</DOC>